China NMPA Drug Inspection - Bazhong Kangxin Pharmaceutical Co., Ltd. - Honeysuckle (Chinese medicinal slices)
China NMPA drug inspection for Bazhong Kangxin Pharmaceutical Co., Ltd. published July 22, 2019. Drug: Honeysuckle (Chinese medicinal slices). The Sichuan Provincial Drug Administration released its Third Issue of the 2019 Drug Quality Bulletin on July 22, 2019,
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Bazhong Kangxin Pharmaceutical Co., Ltd. published July 22, 2019. Drug: Honeysuckle (Chinese medicinal slices). The Sichuan Provincial Drug Administration released its Third Issue of the 2019 Drug Quality Bulletin on July 22, 2019,
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox